• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Evolving Surgical Strategies for Treatment of Gastric Cancer with Peritoneal Carcinomatosis.

作者信息

Khomiak Andrii, Ghaffar Sumaya, McCarter Martin D, Ahrendt Steven, Mungo Benedetto

机构信息

Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA.

出版信息

Ann Surg Oncol. 2024 Dec;31(13):8598-8599. doi: 10.1245/s10434-024-16239-z. Epub 2024 Sep 18.

DOI:10.1245/s10434-024-16239-z
PMID:39292399
Abstract
摘要

相似文献

1
ASO Author Reflections: Evolving Surgical Strategies for Treatment of Gastric Cancer with Peritoneal Carcinomatosis.《美国外科医师学会（ASO）作者反思：胃癌伴腹膜转移的外科治疗策略演变》
Ann Surg Oncol. 2024 Dec;31(13):8598-8599. doi: 10.1245/s10434-024-16239-z. Epub 2024 Sep 18.
2
ASO Author Reflections: Current Status of Treatment of Peritoneal Carcinomatosis from Gastric Cancer Origin in Spain: Is It Possible to Cure These Patients?
Ann Surg Oncol. 2019 Dec;26(Suppl 3):792-793. doi: 10.1245/s10434-019-07952-1. Epub 2019 Oct 18.
3
ASO Author Reflections: Using the Gastric Cancer Peritoneal Carcinomatosis Risk Score to Inform Surveillance and Treatment.ASO作者反思：利用胃癌腹膜转移风险评分指导监测与治疗
Ann Surg Oncol. 2020 Jan;27(1):248-249. doi: 10.1245/s10434-019-08000-8. Epub 2019 Oct 28.
4
ASO Author Reflections: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis: A Systematic Review and Meta-Analysis.ASO作者反思：减瘤手术联合腹腔热灌注化疗治疗伴腹膜转移的胃癌：一项系统评价和荟萃分析
Ann Surg Oncol. 2022 Nov;29(12):7538-7539. doi: 10.1245/s10434-022-12317-2. Epub 2022 Jul 30.
5
ASO Author Reflections: Real-World Incidence of Peritoneal Carcinomatosis After Colon Cancer Resection and Why It Matters.ASO作者反思：结肠癌切除术后腹膜癌转移的真实世界发病率及其重要性
Ann Surg Oncol. 2020 Dec;27(13):4949. doi: 10.1245/s10434-020-08773-3. Epub 2020 Jul 6.
6
ASO Author Reflections: Circulating Tumor DNA in Peritoneal Carcinomatosis.ASO作者反思：腹膜癌病中的循环肿瘤DNA
Ann Surg Oncol. 2018 Dec;25(Suppl 3):772-773. doi: 10.1245/s10434-018-7029-x. Epub 2018 Nov 12.
7
ASO Author Reflections: Postoperative Inflammatory Markers as a Surveillance Tool in Colorectal Peritoneal Carcinomatosis.ASO作者反思：术后炎症标志物作为结直肠腹膜癌转移的监测工具
Ann Surg Oncol. 2021 Oct;28(11):6636-6637. doi: 10.1245/s10434-021-09733-1. Epub 2021 Mar 17.
8
ASO Author Reflections: Use of Peritoneal Cancer Index (PCI) to Evaluate Carcinomatosis in Ovarian Cancer.ASO作者反思：使用腹膜癌指数（PCI）评估卵巢癌中的癌转移。
Ann Surg Oncol. 2020 Dec;27(Suppl 3):763-764. doi: 10.1245/s10434-020-08664-7. Epub 2020 May 28.
9
ASO Author Reflections: Achieving Long-Term Survival in Patients with Peritoneal Carcinomatosis of Colorectal Origin.ASO作者反思：实现结直肠源性腹膜癌患者的长期生存
Ann Surg Oncol. 2024 Mar;31(3):2010-2011. doi: 10.1245/s10434-023-14707-6. Epub 2023 Dec 8.
10
ASO Author Reflections: Targeting the Immunosuppressive Tumor Microenvironment for Treating Peritoneal Carcinomatosis of Gastrointestinal and Pancreaticobiliary Cancer.
Ann Surg Oncol. 2020 Dec;27(Suppl 3):759-760. doi: 10.1245/s10434-020-08640-1. Epub 2020 May 25.

本文引用的文献

1
Updates on global epidemiology, risk and prognostic factors of gastric cancer.全球胃癌流行病学、风险和预后因素的最新研究进展。
World J Gastroenterol. 2023 Apr 28;29(16):2452-2468. doi: 10.3748/wjg.v29.i16.2452.
2
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.胃癌：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2022 Oct;33(10):1005-1020. doi: 10.1016/j.annonc.2022.07.004. Epub 2022 Jul 29.
3
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
氟尿嘧啶+亚叶酸、奥沙利铂和多西紫杉醇与氟尿嘧啶或卡培他滨+顺铂和表柔比星用于局部晚期可切除胃或胃食管交界处腺癌的围手术期化疗（FLOT4）：一项随机、2/3 期试验。
Lancet. 2019 May 11;393(10184):1948-1957. doi: 10.1016/S0140-6736(18)32557-1. Epub 2019 Apr 11.
4
Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors.胃源性腹膜癌：基于人群的发病率、生存率和危险因素研究。
Int J Cancer. 2014 Feb 1;134(3):622-8. doi: 10.1002/ijc.28373. Epub 2013 Aug 5.
5
Adjuvant hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) associated with curative surgery for locally advanced gastric carcinoma. An initial experience.辅助性术中腹腔内热化疗（HIPEC）联合根治性手术治疗局部进展期胃癌：初步经验。
Acta Chir Belg. 2006 May-Jun;106(3):297-301. doi: 10.1080/00015458.2006.11679896.
6
Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion.通过腹膜切除术和腹腔热灌注化疗治疗胃癌腹膜转移
Br J Surg. 2005 Mar;92(3):370-5. doi: 10.1002/bjs.4695.
7
Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery.
Cancer. 1997 Mar 1;79(5):884-91. doi: 10.1002/(sici)1097-0142(19970301)79:5<884::aid-cncr3>3.0.co;2-c.
8
Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy.
Cancer. 1991 Oct 1;68(7):1501-6. doi: 10.1002/1097-0142(19911001)68:7<1501::aid-cncr2820680706>3.0.co;2-l.